Gentamicin in infective endocarditis: how to use it?
Gentamicin in infective endocarditis: how to use it?
复制标题
庆大霉素治疗感染性心内膜炎：如何使用？
DOI：
--
复制
发表时间：
2009
影响因子：
11.8
通讯作者：
M. Moutschen
中科院分区：
文献类型：
--
作者：
F. Frippiat;K. Chandrikakumari;M. Moutschen
出现症状或 ALT 110 正常上限之前 6 周（以先到者为准）。因此，不可能在 ATAHC HIV 阳性受试者和 ATAHC HIV 阴性受试者之间就该变量进行比较，也不可能与德国受试者进行任何比较。然而，我们的数据确实与德国研究的结论一致。对于出现临床 HCV 感染的 ATAHC HIV 阳性受试者，我们观察到，与通过注射吸毒传播的受试者（11 周）相比，性传播受试者（24 周）从估计感染日期到研究入组的中位间隔更长（11 周）。这可能 P p = .045 表明检测或转诊的延迟以及对当前不具有 HCV 感染传统危险因素的 HIV 阳性男性中急性 HCV 感染流行的认识缺乏。我们支持 Vogel 等人 [1] 的呼吁，即加强有关这一问题的公共卫生信息，并需要对处于危险中的艾滋病毒阳性男性进行频繁和早期的急性丙型肝炎病毒感染检测。
symptoms or 6 weeks prior to ALT 110 upper limit of normal (whichever came first). A comparison between the ATAHC HIV-positive and the ATAHC HIV-negative subjects with regard to this variable is therefore not possible, nor is any comparison with the German subjects. However, our data do agree with the German study in our conclusions. For ATAHC HIV-positive subjects who presented with clinical HCV infection, we observed a longer median interval from the estimated date of infection to the presentation for study enrollment for subjects with sexual transmission (24 weeks) versus for subjects with transmission via injection drug use (11 weeks) ( ). This may P p .045 suggest delayed testing or referral and a lack of awareness of the current epidemic of acute HCV infection in HIV-positive men who do not have traditional risk factors for HCV infection. We support the call by Vogel et al [1] for enhanced public health messages on this issue and the need for frequent and early testing for acute HCV infection in HIV-positive men at risk.